Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 15021 | 15.75 |
09:34 ET | 3041 | 15.73 |
09:36 ET | 2200 | 15.82 |
09:38 ET | 1846 | 15.825 |
09:39 ET | 300 | 15.85 |
09:41 ET | 10797 | 15.775 |
09:43 ET | 600 | 15.74 |
09:45 ET | 2015 | 15.81 |
09:48 ET | 792 | 15.7821 |
09:50 ET | 9239 | 15.75 |
09:52 ET | 400 | 15.77 |
09:54 ET | 500 | 15.735 |
09:56 ET | 7326 | 15.81 |
09:57 ET | 5090 | 15.8 |
09:59 ET | 607 | 15.78 |
10:01 ET | 3919 | 15.79 |
10:03 ET | 1165 | 15.79 |
10:06 ET | 1552 | 15.7807 |
10:08 ET | 300 | 15.775 |
10:10 ET | 1000 | 15.78 |
10:12 ET | 1513 | 15.8 |
10:14 ET | 1174 | 15.78 |
10:15 ET | 549 | 15.76 |
10:17 ET | 2130 | 15.775 |
10:19 ET | 250 | 15.77 |
10:21 ET | 1786 | 15.79 |
10:24 ET | 2936 | 15.79 |
10:26 ET | 7081 | 15.825 |
10:28 ET | 10041 | 15.82 |
10:30 ET | 19697 | 15.82 |
10:32 ET | 2843 | 15.82 |
10:33 ET | 14760 | 15.81 |
10:35 ET | 1939 | 15.81 |
10:37 ET | 1430 | 15.81 |
10:39 ET | 12600 | 15.83 |
10:42 ET | 1941 | 15.85 |
10:44 ET | 7516 | 15.91 |
10:46 ET | 2435 | 15.93 |
10:48 ET | 3632 | 15.96 |
10:50 ET | 3520 | 15.96 |
10:51 ET | 5683 | 15.935 |
10:53 ET | 2050 | 15.93 |
10:55 ET | 4457 | 15.96 |
10:57 ET | 676 | 15.96 |
11:00 ET | 5604 | 15.99 |
11:02 ET | 3877 | 16.03 |
11:04 ET | 2542 | 15.96 |
11:06 ET | 7281 | 15.94 |
11:08 ET | 917 | 15.94 |
11:09 ET | 700 | 15.93 |
11:11 ET | 3419 | 15.935 |
11:13 ET | 978 | 15.93 |
11:15 ET | 300 | 15.93 |
11:18 ET | 1714 | 15.9252 |
11:20 ET | 500 | 15.96 |
11:22 ET | 300 | 15.94 |
11:24 ET | 2011 | 15.92 |
11:26 ET | 1065 | 15.9487 |
11:27 ET | 806 | 15.92 |
11:29 ET | 400 | 15.92 |
11:31 ET | 1271 | 15.93 |
11:33 ET | 1907 | 15.985 |
11:36 ET | 3991 | 16 |
11:38 ET | 1300 | 15.99 |
11:40 ET | 1749 | 15.95 |
11:42 ET | 2045 | 15.94 |
11:44 ET | 3652 | 15.95 |
11:45 ET | 200 | 15.94 |
11:47 ET | 500 | 15.97 |
11:49 ET | 2156 | 15.98 |
11:51 ET | 200 | 15.97 |
11:54 ET | 400 | 15.96 |
11:56 ET | 803 | 15.97 |
11:58 ET | 3700 | 15.97 |
12:00 ET | 400 | 15.98 |
12:02 ET | 100 | 15.97 |
12:03 ET | 12714 | 15.98 |
12:07 ET | 990 | 15.97 |
12:09 ET | 1200 | 15.9599 |
12:12 ET | 100 | 15.955 |
12:14 ET | 2204 | 15.935 |
12:16 ET | 4619 | 15.905 |
12:18 ET | 1197 | 15.94 |
12:20 ET | 2805 | 15.985 |
12:21 ET | 2424 | 15.99 |
12:23 ET | 318 | 15.992 |
12:25 ET | 1000 | 16.01 |
12:27 ET | 2079 | 15.99 |
12:30 ET | 3163 | 15.99 |
12:32 ET | 243 | 15.99 |
12:34 ET | 705 | 15.98 |
12:36 ET | 2400 | 15.97 |
12:38 ET | 500 | 15.97 |
12:39 ET | 6031 | 15.961 |
12:41 ET | 200 | 15.97 |
12:45 ET | 800 | 15.96 |
12:48 ET | 1014 | 15.96 |
12:52 ET | 2200 | 15.965 |
12:54 ET | 12550 | 15.97 |
12:56 ET | 200 | 15.97 |
12:57 ET | 669 | 15.97 |
12:59 ET | 900 | 15.97 |
01:01 ET | 6645 | 16 |
01:03 ET | 2936 | 16.04 |
01:06 ET | 7577 | 16.11 |
01:08 ET | 1423 | 16.07 |
01:10 ET | 200 | 16.04 |
01:12 ET | 600 | 16.03 |
01:15 ET | 2019 | 16.07 |
01:17 ET | 2841 | 16.06 |
01:19 ET | 3672 | 16.07 |
01:21 ET | 3889 | 16.07 |
01:24 ET | 1350 | 16.06 |
01:26 ET | 1855 | 16.0701 |
01:28 ET | 2404 | 16.08 |
01:30 ET | 950 | 16.1 |
01:32 ET | 950 | 16.1 |
01:33 ET | 2382 | 16.095 |
01:35 ET | 2679 | 16.09 |
01:37 ET | 833 | 16.06 |
01:39 ET | 948 | 16.0383 |
01:42 ET | 840 | 16.03 |
01:44 ET | 3466 | 16.05 |
01:46 ET | 100 | 16.045 |
01:48 ET | 2759 | 16.04 |
01:50 ET | 400 | 16.05 |
01:51 ET | 539 | 16.06 |
01:53 ET | 500 | 16.04 |
01:55 ET | 6786 | 16.015 |
01:57 ET | 2129 | 15.965 |
02:00 ET | 2451 | 15.97 |
02:02 ET | 1743 | 16 |
02:04 ET | 1657 | 15.975 |
02:06 ET | 1100 | 15.985 |
02:08 ET | 1412 | 15.99 |
02:09 ET | 1939 | 15.965 |
02:11 ET | 17995 | 15.9 |
02:13 ET | 2386 | 15.92 |
02:15 ET | 2552 | 15.92 |
02:18 ET | 430 | 15.92 |
02:20 ET | 2732 | 15.89 |
02:22 ET | 2628 | 15.89 |
02:24 ET | 4517 | 15.86 |
02:26 ET | 910 | 15.86 |
02:27 ET | 2790 | 15.86 |
02:29 ET | 6067 | 15.86 |
02:31 ET | 1603 | 15.82 |
02:33 ET | 3721 | 15.81 |
02:36 ET | 1466 | 15.8 |
02:38 ET | 2218 | 15.79 |
02:40 ET | 1000 | 15.8 |
02:42 ET | 698 | 15.81 |
02:44 ET | 5688 | 15.81 |
02:45 ET | 700 | 15.81 |
02:47 ET | 6235 | 15.81 |
02:49 ET | 850 | 15.825 |
02:51 ET | 4002 | 15.815 |
02:54 ET | 1184 | 15.81 |
02:56 ET | 926 | 15.82 |
02:58 ET | 2575 | 15.82 |
03:00 ET | 1614 | 15.815 |
03:02 ET | 500 | 15.81 |
03:03 ET | 2955 | 15.8 |
03:05 ET | 2507 | 15.8 |
03:07 ET | 900 | 15.79 |
03:09 ET | 2815 | 15.8 |
03:12 ET | 2618 | 15.79 |
03:14 ET | 2623 | 15.79 |
03:16 ET | 1157 | 15.785 |
03:18 ET | 2204 | 15.81 |
03:20 ET | 1100 | 15.81 |
03:21 ET | 1408 | 15.79 |
03:23 ET | 1416 | 15.81 |
03:25 ET | 3551 | 15.77 |
03:27 ET | 3675 | 15.765 |
03:30 ET | 2502 | 15.78 |
03:32 ET | 4772 | 15.75 |
03:34 ET | 13660 | 15.78 |
03:36 ET | 4796 | 15.78 |
03:38 ET | 4611 | 15.76 |
03:39 ET | 1763 | 15.76 |
03:41 ET | 3757 | 15.75 |
03:43 ET | 3581 | 15.745 |
03:45 ET | 5265 | 15.74 |
03:48 ET | 4723 | 15.76 |
03:50 ET | 5941 | 15.755 |
03:52 ET | 7101 | 15.78 |
03:54 ET | 3161 | 15.78 |
03:56 ET | 16552 | 15.76 |
03:57 ET | 39087 | 15.725 |
03:59 ET | 224770 | 15.69 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.7B | 86.5x | --- |
Azenta Inc | 2.4B | -17.5x | --- |
PTC Therapeutics Inc | 2.6B | -5.9x | --- |
Guardant Health Inc | 3.3B | -5.6x | --- |
Novavax Inc | 2.2B | -4.8x | --- |
Genmab A/S | 17.4B | 19.4x | +22.71% |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $890.5M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $0.18 |
Book Value | $2.62 |
P/E Ratio | 86.5x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 64.4x |
Operating Margin | 2.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.